使用SF-12替代SF-36构建改良银屑病关节炎疾病活动度评分的开发研究
本研究在100例符合CASPAR标准的银屑病关节炎患者中,用SF-12替代SF-36构建改良PASDAS(mPASDAS),并与原PASDAS比较一致性。结果显示两评分相关性0.998(P<0.0001),平均差异-0.05(95%CI -0.07,-0.03),误分类率仅6%,加权κ=0.90(95%CI 0.82,0.97),mPASDAS可替代PASDAS用于疾病活动度评估。
要点
- mPASDAS与PASDAS高度一致,相关系数0.998(P<0.0001)。
- 两评分平均差异-0.05(95%CI -0.07,-0.03),误分类率仅6%。
- 疾病活动状态一致性加权κ=0.90(95%CI 0.82,0.97)。
核心结论
- mPASDAS与PASDAS一致性极佳、结构效度好且误分类率低,可替代PASDAS用于银屑病关节炎疾病活动度评估。
研究设计与样本
- 连续纳入100例符合CASPAR分类标准的银屑病关节炎患者,从SF-36问卷中提取SF-12的12个条目反应,分别计算PASDAS和mPASDAS。
- 采用Bland-Altman图评估两评分一致性,通过与其他健康测量工具的相关性评估结构效度,用κ统计量衡量疾病活动状态一致性。
主要发现
- PASDAS和mPASDAS均值±标准差分别为3.29±1.39和3.24±1.27。
- 两评分相关系数0.998(P<0.0001),平均差异-0.05(95%CI -0.07,-0.03)。
- PASDAS和mPASDAS与各外部健康测量工具的相关性几乎一致,mPASDAS误分类率仅6%。
- 疾病活动状态一致性加权κ=0.90(95%CI 0.82,0.97)。
关键数值与推荐
- mPASDAS与PASDAS平均差异-0.05(95%CI -0.07,-0.03),相关系数0.998(P<0.0001)。
- 疾病活动状态一致性加权κ=0.90(95%CI 0.82,0.97),误分类率6%。
临床怎么用
- 在临床或研究中可用mPASDAS替代PASDAS评估银屑病关节炎疾病活动度,以减轻问卷负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Psoriatic Arthritis Disease Activity Score (PASDAS) is a composite measure of psoriatic arthritis (PsA) disease activity. The length of its patient-reported components raises concern about questionnaire burden. The PASDAS includes the Medical Outcomes Study Short Form 36 (SF-36) health survey. We undertook this study to investigate the agreement between the PASDAS and a modified PASDAS (mPASDAS), which substituted the SF-36 with the shortened SF-12. METHODS: A total of 100 patients who fulfilled the criteria of the Classification of Psoriatic Arthritis Study Group for PsA were consecutively recruited. All of the PASDAS-required variables were collected. The 12 item responses for SF-12 were extracted from the SF-36 questionnaire. The PASDAS and the mPASDAS were calculated using the SF-36 and SF-12 scores, respectively. A Bland-Altman plot of the mean differences in PASDAS and mPASDAS scores was generated to evaluate agreement. Construct validity was assessed by examining correlations of the PASDAS and the mPASDAS with the Health Assessment Questionnaire, the Functional Assessment of Chronic Illness Therapy-Fatigue subscale, the EuroQol 5-domain instrument (health-related quality of life), and pain scores (range 0-10, visual analog scale). The kappa statistic was used to measure agreement between disease activity states as determined by the PASDAS and mPASDAS. RESULTS: The mean ± SD PASDAS and mPASDAS was 3.29 ± 1.39 and 3.24 ± 1.27, respectively. The correlation between the 2 scores was 0.998 (P < 0.0001), and the mean difference was -0.05 (95% confidence interval [95% CI] -0.07, -0.03). Construct validity was found, with nearly identical correlations of the PASDAS and mPASDAS with each of the external health measures. The misclassification rate with the mPASDAS was only 6%. The weighted κ = 0.90 (95% CI 0.82, 0.97). CONCLUSION: The mPASDAS may replace the PASDAS in disease activity assessment given the excellent agreement, validity, and low misclassification rate.
引用
- Perruccio AV, Got M, Li S, et al. Development of a Modified Psoriatic Arthritis Disease Activity Score Using the Medical Outcomes Study Short Form 12 as a Measure of Quality of Life. Arthritis Care Res (Hoboken). 2020. PMID: 30875460. doi:10.1002/acr.23876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。